Translational Pharmacology
Translational pharmacology pursues research at the interface of non-clinical and clinical sciences. Our scientific focus is the personalization of drug therapy for chronic diseases. We investigate mechanisms of variability in therapeutic and adverse drug effects using laboratory experiments and carefully conducted proof-of-concept clinical studies.
We are particularly interested in lipid mediators within the eicosanoid biosynthetic response pathway. Most cells in the organism can synthesize eicosanoids, which play important regulatory roles in many physiological and pathological processes. These include inflammation, inflammatory pain, blood pressure regulation, atherosclerosis, thrombosis, tumor growth, and immunity. We conduct deep-phenotyping studies in model systems and humans, involving precise measurements of molecular network topologies and dynamics using omics technologies.
We are a member laboratory of the interdisciplinary Center for Biotechnology (CeBiTec).
Selected Publications | Clinical Research Studies
People
Tilo Grosser, M.D.
Professor and Chair of Translational Pharmacology
Member, Center for Biotechnology (CeBiTec)↗
Team Assistant
Carolin Mönter
carolin.moenter@uni-bielefeld.de
+49 521 106-86213
Office: R.2 B2-215
Laboratory Technical Assistant
Jennifer Becker
+49 521 106-82550
Systems Pharmacology
Lenny Ferrer, Ph.D.
Viktoria Fulek, M.Sc.
Vanessa Schmidt, Ph.D.
Michelle Schwab, M.Sc.
Debora Tibbe, Ph.D.
Cardiovascular Pharmacology
Jörg Wegener, Ph.D., Senior Lecturer
(Curriculum development)
Lina Broeckelmann, B.Sc.
Maja Stuke, B.Sc.
Katharina Graf, cand.med.
Immunology
Bianca Jütte, PhD
Till Knauf, cand. med.
Bioinformatics
Fabian Banze, B.Sc.
Clinical Research
Insa Wingendorf, MPH
Kim Reiling, MD (Clinician Scientist)
Udo Krause
Sarah Guttmann, PhD
